Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Arbyn

Showing results (41-50 of 308) with videos related to

Pageof 31
Sort By:
The Lancet. Oncology|November 16, 2010
HPV-based cervical-cancer screening in ChinaMarc Arbyn, Amy Walker, Chris J L M Meijer
Journal of Clinical Microbiology|April 5, 2020
Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 FrameworkLan Xu, Anja Oštrbenk Valenčak, Mario Poljak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 11, 2025
Accuracy of HPV Self-Collection Compared with Clinician-Collected HPV Testing and Cytology: A Meta-analysisSarah A Phillips, Sophie Denoël, Nicolas Wentzensen, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 21, 2017
Pregnancy outcome after cervical conisation: A 2nd retrospective cohort study in the Leuven University HospitalKim van Velthoven, Willy Poppe, Hannah Verschuere, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2022
Response to the letter entitled: Re: 'Prognostic value of high-risk HPV DNA and p16<sup>INK4a</sup> immunohistochemistry in anal cancer patients: An individual patient data meta-analysis'Theresa Obermueller, Joris Hautekiet, Elena-Sophie Prigge, et al.
Clinical Trials (London, England)|October 2, 2008
Avoiding verification bias in screening test evaluation in resource poor settings: a case study from ZimbabweLynne Gaffikin, John McGrath, Marc Arbyn, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 4, 2015
HPV testing in the context of post-treatment follow up (test of cure)Kate Cuschieri, Ramya Bhatia, Margaret Cruickshank, et al.
American Journal of Obstetrics and Gynecology|May 6, 2008
Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective studySilke Schockaert, Willy Poppe, Marc Arbyn, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2009
What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccinationElsebeth Lynge, Ahti Antilla, Marc Arbyn, et al.
The Cochrane Database of Systematic Reviews|May 10, 2018
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsMarc Arbyn, Lan Xu, Cindy Simoens, et al.
Pageof 31

Showing results (41-50 of 308) with videos related to

Sort By:
Pageof 31
The Lancet. Oncology|November 16, 2010
HPV-based cervical-cancer screening in ChinaMarc Arbyn, Amy Walker, Chris J L M Meijer
Journal of Clinical Microbiology|April 5, 2020
Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 FrameworkLan Xu, Anja Oštrbenk Valenčak, Mario Poljak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 11, 2025
Accuracy of HPV Self-Collection Compared with Clinician-Collected HPV Testing and Cytology: A Meta-analysisSarah A Phillips, Sophie Denoël, Nicolas Wentzensen, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 21, 2017
Pregnancy outcome after cervical conisation: A 2nd retrospective cohort study in the Leuven University HospitalKim van Velthoven, Willy Poppe, Hannah Verschuere, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2022
Response to the letter entitled: Re: 'Prognostic value of high-risk HPV DNA and p16<sup>INK4a</sup> immunohistochemistry in anal cancer patients: An individual patient data meta-analysis'Theresa Obermueller, Joris Hautekiet, Elena-Sophie Prigge, et al.
Clinical Trials (London, England)|October 2, 2008
Avoiding verification bias in screening test evaluation in resource poor settings: a case study from ZimbabweLynne Gaffikin, John McGrath, Marc Arbyn, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 4, 2015
HPV testing in the context of post-treatment follow up (test of cure)Kate Cuschieri, Ramya Bhatia, Margaret Cruickshank, et al.
American Journal of Obstetrics and Gynecology|May 6, 2008
Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective studySilke Schockaert, Willy Poppe, Marc Arbyn, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2009
What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccinationElsebeth Lynge, Ahti Antilla, Marc Arbyn, et al.
The Cochrane Database of Systematic Reviews|May 10, 2018
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsMarc Arbyn, Lan Xu, Cindy Simoens, et al.
Pageof 31